| abstract |
The present invention relates to novel contraceptive formulations for women of childbearing age, based on nomegestrolone and / or ester, and estradiolone and / or ester, in an optimal ratio of <estrogenic fraction dose <to <progesterone fraction dose < and ranges from 1 to 5, wherein the composition is a mixture of the two components or a mixture of an inert, non-toxic, pharmaceutically acceptable diluent or carrier. SHE |